CR20230123A - Síntesis de compuestos de quinazolina - Google Patents
Síntesis de compuestos de quinazolinaInfo
- Publication number
- CR20230123A CR20230123A CR20230123A CR20230123A CR20230123A CR 20230123 A CR20230123 A CR 20230123A CR 20230123 A CR20230123 A CR 20230123A CR 20230123 A CR20230123 A CR 20230123A CR 20230123 A CR20230123 A CR 20230123A
- Authority
- CR
- Costa Rica
- Prior art keywords
- synthesis
- quinazoline compounds
- compounds
- quinazoline
- atropisomeric
- Prior art date
Links
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
En la presente se proporcionan métodos para sintetizar compuestos de quinazolina que comprenden al menos un centro atropisomérico.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063064746P | 2020-08-12 | 2020-08-12 | |
| PCT/US2021/045297 WO2022035790A1 (en) | 2020-08-12 | 2021-08-10 | Synthesis of quinazoline compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20230123A true CR20230123A (es) | 2023-04-19 |
Family
ID=77543703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20230123A CR20230123A (es) | 2020-08-12 | 2021-08-10 | Síntesis de compuestos de quinazolina |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20220081413A1 (es) |
| EP (1) | EP4196470A1 (es) |
| JP (1) | JP2023537999A (es) |
| KR (1) | KR20230049679A (es) |
| CN (1) | CN116057052A (es) |
| AR (1) | AR123200A1 (es) |
| AU (2) | AU2021325869C1 (es) |
| BR (1) | BR112023002591A2 (es) |
| CA (1) | CA3191001A1 (es) |
| CL (1) | CL2023000395A1 (es) |
| CR (1) | CR20230123A (es) |
| IL (1) | IL300309A (es) |
| MX (1) | MX2023001682A (es) |
| PE (1) | PE20230733A1 (es) |
| TW (1) | TWI829003B (es) |
| WO (1) | WO2022035790A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023150706A1 (en) * | 2022-02-07 | 2023-08-10 | Genentech, Inc. | Solid forms of 1-((s)-4-((r)-7-(6-amino-4-methyl-3- (trifluoromethyl)pyridin-2-yl)-6-chloro-8-fluoro-2-(((s)-1- methylpyrrolidin-2-yl)methoxy)quinazolin-4-yl)-3- methylpiperazin-1-yl)prop-2-en-1-one |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2727036C (en) | 2008-06-20 | 2017-03-21 | Genentech, Inc. | Triazolopyridine jak inhibitor compounds and methods |
| CN105037333A (zh) * | 2009-12-21 | 2015-11-11 | 张强 | 新的喹唑啉衍生物 |
| JP2013107855A (ja) * | 2011-11-22 | 2013-06-06 | Mitsubishi Tanabe Pharma Corp | 医薬組成物 |
| UA119971C2 (uk) * | 2013-10-10 | 2019-09-10 | Араксіс Фарма Ллк | Інгібітори g12c kras |
| WO2017100546A1 (en) * | 2015-12-09 | 2017-06-15 | Araxes Pharma Llc | Methods for preparation of quinazoline derivatives |
| CN118084870A (zh) * | 2018-11-09 | 2024-05-28 | 豪夫迈·罗氏有限公司 | 稠环化合物 |
-
2021
- 2021-08-10 US US17/398,345 patent/US20220081413A1/en active Pending
- 2021-08-10 KR KR1020237007998A patent/KR20230049679A/ko unknown
- 2021-08-10 EP EP21762952.6A patent/EP4196470A1/en active Pending
- 2021-08-10 WO PCT/US2021/045297 patent/WO2022035790A1/en active Application Filing
- 2021-08-10 CA CA3191001A patent/CA3191001A1/en active Pending
- 2021-08-10 AR ARP210102232A patent/AR123200A1/es unknown
- 2021-08-10 TW TW110129429A patent/TWI829003B/zh active
- 2021-08-10 PE PE2023000241A patent/PE20230733A1/es unknown
- 2021-08-10 CR CR20230123A patent/CR20230123A/es unknown
- 2021-08-10 JP JP2023509849A patent/JP2023537999A/ja active Pending
- 2021-08-10 AU AU2021325869A patent/AU2021325869C1/en active Active
- 2021-08-10 BR BR112023002591A patent/BR112023002591A2/pt unknown
- 2021-08-10 CN CN202180056371.XA patent/CN116057052A/zh active Pending
- 2021-08-10 IL IL300309A patent/IL300309A/en unknown
- 2021-08-10 MX MX2023001682A patent/MX2023001682A/es unknown
-
2023
- 2023-02-07 CL CL2023000395A patent/CL2023000395A1/es unknown
-
2024
- 2024-01-12 AU AU2024200220A patent/AU2024200220A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220081413A1 (en) | 2022-03-17 |
| EP4196470A1 (en) | 2023-06-21 |
| CN116057052A (zh) | 2023-05-02 |
| TW202214596A (zh) | 2022-04-16 |
| WO2022035790A1 (en) | 2022-02-17 |
| CA3191001A1 (en) | 2022-02-17 |
| CL2023000395A1 (es) | 2023-07-28 |
| JP2023537999A (ja) | 2023-09-06 |
| KR20230049679A (ko) | 2023-04-13 |
| AU2024200220A1 (en) | 2024-02-01 |
| MX2023001682A (es) | 2023-02-22 |
| TWI829003B (zh) | 2024-01-11 |
| AR123200A1 (es) | 2022-11-09 |
| AU2021325869A1 (en) | 2023-02-23 |
| AU2021325869C1 (en) | 2024-05-30 |
| BR112023002591A2 (pt) | 2023-04-04 |
| IL300309A (en) | 2023-04-01 |
| PE20230733A1 (es) | 2023-05-03 |
| AU2021325869B2 (en) | 2024-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019231551A8 (en) | Substituted 1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-ones | |
| CY1112117T1 (el) | Υδροξυλιωμενες και μεθοξυλιωμενες κυκλοπεντα[d]πυριμιδινες ως αναστολεις ακτ πρωτεϊνικης κινασης | |
| MX2020001235A (es) | Análogos de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona. | |
| MX2019011468A (es) | Sintesis de inhibidor de mcl-1. | |
| GEP20217281B (en) | 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer | |
| MX2022005726A (es) | Sintesis mejorada del compuesto inhibidor de g12c de kras. | |
| PH12019550140A1 (en) | Piperidine-substituted mnk inhibitors and methods related thereto | |
| MX2022005708A (es) | Sintesis mejorada del compuesto inhibidor de g12c de kras. | |
| MX361116B (es) | Métodos para sintetizar bloque de construcción de amatoxina y amatoxinas. | |
| CR20220626A (es) | Compuestos para el tratamiento de enfermedades y trastornos asociados a braf | |
| MY150214A (en) | Kinesin inhibitors as cancer therapeutics | |
| PH12018502337A1 (en) | Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions | |
| MX2023010429A (es) | Inhibidores del homologo del oncogen viral del sarcoma de rata kirsten (kras). | |
| MX2022012671A (es) | Vacuna terapeutica individualizada contra el cancer. | |
| MX2022005229A (es) | Un nuevo proceso eficaz para la sintesis de 2-amino-5-cloro-n,3-di metilbenzamida. | |
| MX2023001682A (es) | Sintesis de compuestos de quinazolina. | |
| MX2023006606A (es) | Derivados biciclicos. | |
| MX2021011608A (es) | Metodos ex vivo para producir celulas t terapeuticas y composiciones y metodos afines. | |
| MX2022006142A (es) | Proceso para la sintesis de (3-cloro-2-piridil)hidrazina. | |
| IL279168B (en) | A process for the preparation of eribulin | |
| TW202423916A (zh) | 喹唑啉化合物之合成 | |
| PH12020550594A1 (en) | New alcoxyamino derivatives for treating pain and pain related conditions | |
| MX2022001549A (es) | Nuevas sintesis telescopicas de 2-metoximetil-p-fenilendiamina. | |
| MX2022014838A (es) | Métodos para sintetizar farnesil dibenzodiazepinonas. | |
| PH12021550320A1 (en) | Bicyclic heteroaryl derivatives |